Home » Newsletters » BioWorld Asia

BioWorld Asia

May 12, 1999

View Archived Issues

Hard Times Force Amrad To Restructure, Refocus

OGS Unloads Biochemicals, Pushes Proteomics Research

Thymus Atrophy In Clone Shows Long-Term Effects Of Using Adult Somatic Cells

Foresight Study Recommends: Commit IEP70M To Biotech

New Tech-Transfer Firm Focused On Cancer Work

Polymasc, Onyx Sign Deal For Virus Coating Product

York University Spin-Out Funded For DEP Efforts

Venture Group, Government Seeking CEO For New Firm

Genset, Johns Hopkins Enter Schizophrenia Research Deal

Berlin Start-Up Focused On Epigenetics Research

Fidelity Investments Adds C$6M To Theratechnologies

Today's news in brief
BioWorld
BioWorld briefs for Dec. 27, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Probing bidirectional cancer-autoimmune link can yield new targets
BioWorld Science
Cancer and autoimmunity are “often thought of as being at opposite ends of the immune response,” Ana Anderson told her audience at a joint meeting of the NIH’s...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.